These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


198 related items for PubMed ID: 10327057

  • 1. Mutations of the DPC4/Smad4 gene in neuroendocrine pancreatic tumors.
    Bartsch D, Hahn SA, Danichevski KD, Ramaswamy A, Bastian D, Galehdari H, Barth P, Schmiegel W, Simon B, Rothmund M.
    Oncogene; 1999 Apr 08; 18(14):2367-71. PubMed ID: 10327057
    [Abstract] [Full Text] [Related]

  • 2. [Alterations in DPC4 gene in pancreatic cancers].
    Gu L, Chen J, Cui Q.
    Zhonghua Zhong Liu Za Zhi; 2001 Jul 08; 23(4):293-5. PubMed ID: 11783110
    [Abstract] [Full Text] [Related]

  • 3. Status of the DPC4 tumor suppressor gene in sporadic colon adenocarcinoma of Croatian patients: identification of a novel somatic mutation.
    Popović Hadzija M, Radosevic S, Kovacević D, Lukac J, Hadzija M, Spaventi R, Pavelić K, Kapitanović S.
    Mutat Res; 2004 Apr 14; 548(1-2):61-73. PubMed ID: 15063137
    [Abstract] [Full Text] [Related]

  • 4. Expression and mutational analysis of the DCC, DPC4, and MADR2/JV18-1 genes in neuroblastoma.
    Kong XT, Choi SH, Inoue A, Xu F, Chen T, Takita J, Yokota J, Bessho F, Yanagisawa M, Hanada R, Yamamoto K, Hayashi Y.
    Cancer Res; 1997 Sep 01; 57(17):3772-8. PubMed ID: 9288786
    [Abstract] [Full Text] [Related]

  • 5. [Alterations of DPC4/SMAD4/MADH4 gene detected in paraffin-embedded tissues of human pancreatic carcinomas].
    Gu LJ, Chen J, Liu TH, Cui QC, Lu ZH, Li L, Gao J.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Apr 01; 24(2):165-9. PubMed ID: 12905795
    [Abstract] [Full Text] [Related]

  • 6. Mutation of the MENIN gene in sporadic pancreatic endocrine tumors.
    Wang EH, Ebrahimi SA, Wu AY, Kashefi C, Passaro E, Sawicki MP.
    Cancer Res; 1998 Oct 01; 58(19):4417-20. PubMed ID: 9766672
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. DPC4/Smad4: no mutations, rare allelic imbalances, and retained protein expression in pancreatic endocrine tumors.
    Perren A, Saremaslani P, Schmid S, Bonvin C, Locher T, Roth J, Heitz PU, Komminoth P.
    Diagn Mol Pathol; 2003 Dec 01; 12(4):181-6. PubMed ID: 14639103
    [Abstract] [Full Text] [Related]

  • 9. SMAD4 mutations in colorectal cancer probably occur before chromosomal instability, but after divergence of the microsatellite instability pathway.
    Woodford-Richens KL, Rowan AJ, Gorman P, Halford S, Bicknell DC, Wasan HS, Roylance RR, Bodmer WF, Tomlinson IP.
    Proc Natl Acad Sci U S A; 2001 Aug 14; 98(17):9719-23. PubMed ID: 11481457
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Somatic mutations of the MEN1 tumor suppressor gene in sporadic gastrinomas and insulinomas.
    Zhuang Z, Vortmeyer AO, Pack S, Huang S, Pham TA, Wang C, Park WS, Agarwal SK, Debelenko LV, Kester M, Guru SC, Manickam P, Olufemi SE, Yu F, Heppner C, Crabtree JS, Skarulis MC, Venzon DJ, Emmert-Buck MR, Spiegel AM, Chandrasekharappa SC, Collins FS, Burns AL, Marx SJ, Lubensky IA.
    Cancer Res; 1997 Nov 01; 57(21):4682-6. PubMed ID: 9354421
    [Abstract] [Full Text] [Related]

  • 12. Homozygous deletions inactivate DCC, but not MADH4/DPC4/SMAD4, in a subset of pancreatic and biliary cancers.
    Hilgers W, Song JJ, Haye M, Hruban RR, Kern SE, Fearon ER.
    Genes Chromosomes Cancer; 2000 Apr 01; 27(4):353-7. PubMed ID: 10719364
    [Abstract] [Full Text] [Related]

  • 13. Genetics of adenocarcinomas of the small intestine: frequent deletions at chromosome 18q and mutations of the SMAD4 gene.
    Bläker H, von Herbay A, Penzel R, Gross S, Otto HF.
    Oncogene; 2002 Jan 03; 21(1):158-64. PubMed ID: 11791187
    [Abstract] [Full Text] [Related]

  • 14. Comparative mutational analysis of DPC4 (Smad4) in prostatic and colorectal carcinomas.
    MacGrogan D, Pegram M, Slamon D, Bookstein R.
    Oncogene; 1997 Aug 28; 15(9):1111-4. PubMed ID: 9285566
    [Abstract] [Full Text] [Related]

  • 15. DCC and SMAD4 alterations in human colorectal and pancreatic tumor dissemination.
    Tarafa G, Villanueva A, Farré L, Rodríguez J, Musulén E, Reyes G, Seminago R, Olmedo E, Paules AB, Peinado MA, Bachs O, Capellá G.
    Oncogene; 2000 Jan 27; 19(4):546-55. PubMed ID: 10698524
    [Abstract] [Full Text] [Related]

  • 16. Tumor-suppressive pathways in pancreatic carcinoma.
    Rozenblum E, Schutte M, Goggins M, Hahn SA, Panzer S, Zahurak M, Goodman SN, Sohn TA, Hruban RH, Yeo CJ, Kern SE.
    Cancer Res; 1997 May 01; 57(9):1731-4. PubMed ID: 9135016
    [Abstract] [Full Text] [Related]

  • 17. Analysis of specific gene mutations in the transforming growth factor-beta signal transduction pathway in human ovarian cancer.
    Wang D, Kanuma T, Mizunuma H, Takama F, Ibuki Y, Wake N, Mogi A, Shitara Y, Takenoshita S.
    Cancer Res; 2000 Aug 15; 60(16):4507-12. PubMed ID: 10969799
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. No SMAD4 hypermethylation in colorectal cancer.
    Roth S, Laiho P, Salovaara R, Launonen V, Aaltonen LA.
    Br J Cancer; 2000 Oct 15; 83(8):1015-9. PubMed ID: 10993648
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.